GNFT Wutah pendapatan kuartal marang kuartal Genfit Corp

Logo korporat perusahaan genfit.com (GNFT)

Reducing portfolio risks through partnerships with industry behemoths promises stable royalties, as evidenced by quarter-over-quarter revenue growth, where the metric stands at -42.20. Genfit S.A. (GNFT) aims to capture the rare liver pathology niche through expansion; however, geopolitical tensions and logistical complexities are hindering international trials and drug exports.

GNFT (Genfit Corp) riwayat Dinamika pendapatan kuartal marang kuartal saka 04.07.2022 nganti 06.12.2025

genfit.com (GNFT) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:
- indikator dhuwit lan ilining kas:
Analisis umum perusahaan:GNFT - Genfit S.A.
Barang unggulan Genfit S.A.

Genfit S.A. (GNFT) maintains a stable position driven by a consistent stream of licensing payments from liver disease treatments. This indicator measures quarterly revenue growth rates, discounting recent corporate data into a single trend. Investors utilize this balance to assess the effectiveness of long-term partnerships and business liquidity. The final quarterly trading revenue dynamics visualize the growth phases of cash flows.